Invokamet is a combination of canagliflozin and metformin. Invokamet is a daily medication taken orally to treat the symptoms of type 2 diabetes. Invokamet was named in a May 2015 Drug Safety Communication released by the Food and Drug Administration (FDA) warning type 2 diabetes patients taking SGLT2 inhibitors that the medication could lead to serious medical conditions.
If you or a loved one suffered a serious injury while taking Invokamet, you could be entitled to substantial compensation. The Cochran Firm, D.C. is actively investigating Invokamet and other SGLT2 inhibitor related injuries. Contact us for a free Invokamet lawsuit consultation.
What is Invokamet?
Invokamet contains canagliflozin, a type 2 diabetes medication in a class of drugs known as SGLT2 inhibitors. SGLT2 inhibitors treat type 2 diabetes by forcing the body to expel excess blood sugar through urine. The other active ingredient in Invokamet is metformin, which treats type 2 diabetes by suppressing glucose production in the liver.
The FDA warns medications which contain SGLT2 inhibitors, like Invokamet, may be linked to increased risk of serious injuries. The FDA advises Invokamet patients to speak to their doctors before making any changes to their type 2 diabetes medications.
Invokamet ketoacidosis lawsuit
One of the most severe medical conditions linked to taking Invokamet is ketoacidosis. Ketoacidosis is a serious medical condition which may require hospitalization. If not properly treated, ketoacidosis may lead to diabetic coma, cerebral edema, or death.
Ketoacidosis occurs when the body does not have enough insulin to properly metabolize fatty acids known as ketones. Excessive amounts of ketones can cause the blood’s pH to drop. Symptoms of ketoacidosis include:
- Abdominal pain
- Sweet smelling breath
- Frequent urination
- Fatigue or confusion
SGLT2 inhibitors may cause heart attack, stroke, or kidney failure
SGLT2 inhibitors like Invokamet and Invokana are being investigated by healthcare agencies in the United States, Canada, and Europe for possible links to increased risk of heart attack, stroke, and kidney failure. Users of the drug may be eligible to file an Invokana lawsuit to seek compensation for their injuries. SGLT2 inhibitors are a relatively new type of medication and studies about their side effects are ongoing.
Janssen, the maker of Invokamet and Invokana, is currently conducting an FDA-required trial to determine any link between taking Invokana and an increased risk of heart attack or other cardiovascular complications. Independent health care organizations have raised questions about preliminary clinical trials indicating an increased risk of suffering a heart attack, stroke, or kidney failure while taking Invokana.
Invokamet and Invokana lawsuits
If you or a loved one suffered a serious injury while taking Invokamet or Invokana, contact the Invokana injury lawyers of The Cochran Firm, D.C. Our team of product liability attorneys can help you recover compensation for your damages by filing an Invokamet lawsuit. We can file claims for your lost wages, hospital bills, medical expenses, pain and suffering, and other damages.
The Cochran Firm, D.C. offers free, prompt, and confidential Invokamet case reviews. We also represent our Invokamet lawsuit claims on a contingency basis, so there are absolutely no legal fees until we win your case.
Strict time deadlines apply when filing an Invokamet lawsuit. Please contact the Invokamet lawyers at The Cochran Firm, D.C. at 202-682-5800 during business hours or at 1-800-THE-FIRM (843-3476) to reach us 24 hours a day. You may also fill out an online contact form.